(NewsNation) — Widespread use of life-saving artificial blood could be a reality by the end of the decade, according to published reports.
At Nara Medical University in Japan, clinical trials are in progress following the administration of a prototype to a small group of volunteers earlier this year, with no notable side effects observed.
This product utilizes hemoglobin molecules derived from expired donor blood, which are encapsulated in protective lipid shells to form artificial red blood cells. Similar to normal blood, this innovative blend can transport oxygen throughout the body.
Unlike human blood, the artificial version being tested in Japan does not require matching specific blood types for transfusions. Emulating the “universal donor” Type O- blood, this synthetic blood is deemed suitable for any blood type.
What’s more, artificial blood reportedly is storable for up to two years, far longer than organic blood, which cannot be used after 42 days.
Artificial blood is considered a solution to chronic blood bank shortages, which can be especially life-threatening in underdeveloped parts of the world.
Nara Medical University reportedly aims to roll out its artificial blood in 2030, pending the success of its clinical trials.
